nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP19A1—prostate cancer	0.145	0.453	CbGaD
Terbinafine—CYP2C19—prostate cancer	0.107	0.334	CbGaD
Terbinafine—CYP3A4—prostate cancer	0.0683	0.213	CbGaD
Terbinafine—CYP2C8—Nilutamide—prostate cancer	0.0257	0.0623	CbGbCtD
Terbinafine—CYP2C19—Nilutamide—prostate cancer	0.0215	0.0522	CbGbCtD
Terbinafine—CYP2C19—Bicalutamide—prostate cancer	0.0215	0.0522	CbGbCtD
Terbinafine—CYP2C8—Abiraterone—prostate cancer	0.0213	0.0516	CbGbCtD
Terbinafine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0198	0.0481	CbGbCtD
Terbinafine—CYP2C9—Nilutamide—prostate cancer	0.0179	0.0434	CbGbCtD
Terbinafine—CYP2C9—Bicalutamide—prostate cancer	0.0179	0.0434	CbGbCtD
Terbinafine—CYP2C19—Flutamide—prostate cancer	0.0178	0.0433	CbGbCtD
Terbinafine—CYP1A2—Flutamide—prostate cancer	0.0165	0.0399	CbGbCtD
Terbinafine—CYP2D6—Bicalutamide—prostate cancer	0.0164	0.0397	CbGbCtD
Terbinafine—CYP2C8—Cabazitaxel—prostate cancer	0.0157	0.0382	CbGbCtD
Terbinafine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0137	0.0333	CbGbCtD
Terbinafine—CYP2D6—Abiraterone—prostate cancer	0.0136	0.0329	CbGbCtD
Terbinafine—CYP1A2—Estrone—prostate cancer	0.0119	0.0289	CbGbCtD
Terbinafine—CYP2C9—Estrone—prostate cancer	0.0107	0.026	CbGbCtD
Terbinafine—CYP3A4—Bicalutamide—prostate cancer	0.0104	0.0253	CbGbCtD
Terbinafine—PTGS1—Etoposide—prostate cancer	0.00999	0.0242	CbGbCtD
Terbinafine—CYP3A4—Estramustine—prostate cancer	0.00967	0.0235	CbGbCtD
Terbinafine—CYP2C8—Estradiol—prostate cancer	0.00883	0.0214	CbGbCtD
Terbinafine—CYP3A4—Abiraterone—prostate cancer	0.00862	0.0209	CbGbCtD
Terbinafine—CYP3A4—Flutamide—prostate cancer	0.00862	0.0209	CbGbCtD
Terbinafine—CYP2C9—Capecitabine—prostate cancer	0.00812	0.0197	CbGbCtD
Terbinafine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00778	0.0189	CbGbCtD
Terbinafine—CYP2C19—Estradiol—prostate cancer	0.0074	0.018	CbGbCtD
Terbinafine—CYP1A2—Estradiol—prostate cancer	0.00683	0.0166	CbGbCtD
Terbinafine—CYP3A4—Cabazitaxel—prostate cancer	0.00638	0.0155	CbGbCtD
Terbinafine—CYP2C19—Prednisone—prostate cancer	0.00637	0.0155	CbGbCtD
Terbinafine—CYP3A4—Estrone—prostate cancer	0.00623	0.0151	CbGbCtD
Terbinafine—CYP2C9—Estradiol—prostate cancer	0.00616	0.0149	CbGbCtD
Terbinafine—CYP2C8—Etoposide—prostate cancer	0.00576	0.014	CbGbCtD
Terbinafine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00555	0.0135	CbGbCtD
Terbinafine—CYP1A2—Etoposide—prostate cancer	0.00446	0.0108	CbGbCtD
Terbinafine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00408	0.0099	CbGbCtD
Terbinafine—CYP19A1—semen—prostate cancer	0.00383	0.165	CbGeAlD
Terbinafine—CYP3A4—Mitoxantrone—prostate cancer	0.00371	0.009	CbGbCtD
Terbinafine—CYP3A4—Estradiol—prostate cancer	0.00358	0.00869	CbGbCtD
Terbinafine—CYP3A4—Prednisone—prostate cancer	0.00308	0.00747	CbGbCtD
Terbinafine—CYP2D6—Doxorubicin—prostate cancer	0.00251	0.00609	CbGbCtD
Terbinafine—CYP3A4—Etoposide—prostate cancer	0.00234	0.00567	CbGbCtD
Terbinafine—SQLE—prostate gland—prostate cancer	0.00225	0.0974	CbGeAlD
Terbinafine—CYP2C19—urine—prostate cancer	0.00219	0.0948	CbGeAlD
Terbinafine—CYP3A4—Docetaxel—prostate cancer	0.00214	0.00519	CbGbCtD
Terbinafine—CYP1A2—urine—prostate cancer	0.00179	0.0774	CbGeAlD
Terbinafine—CYP2C9—urine—prostate cancer	0.0017	0.0735	CbGeAlD
Terbinafine—CYP3A4—Doxorubicin—prostate cancer	0.00159	0.00387	CbGbCtD
Terbinafine—CYP3A4—urine—prostate cancer	0.0013	0.056	CbGeAlD
Terbinafine—CYP2D6—urine—prostate cancer	0.00128	0.0551	CbGeAlD
Terbinafine—SQLE—testis—prostate cancer	0.000992	0.0429	CbGeAlD
Terbinafine—CYP19A1—prostate gland—prostate cancer	0.000959	0.0415	CbGeAlD
Terbinafine—SQLE—lymph node—prostate cancer	0.000719	0.0311	CbGeAlD
Terbinafine—CYP11A1—testis—prostate cancer	0.00065	0.0281	CbGeAlD
Terbinafine—PTGS1—prostate gland—prostate cancer	0.000557	0.0241	CbGeAlD
Terbinafine—CYP11A1—lymph node—prostate cancer	0.000471	0.0204	CbGeAlD
Terbinafine—PTGS1—seminal vesicle—prostate cancer	0.000471	0.0204	CbGeAlD
Terbinafine—CYP2C8—renal system—prostate cancer	0.000468	0.0202	CbGeAlD
Terbinafine—CYP1A2—renal system—prostate cancer	0.000438	0.0189	CbGeAlD
Terbinafine—CYP19A1—testis—prostate cancer	0.000423	0.0183	CbGeAlD
Terbinafine—PTGS1—epithelium—prostate cancer	0.000409	0.0177	CbGeAlD
Terbinafine—PTGS1—renal system—prostate cancer	0.00038	0.0164	CbGeAlD
Terbinafine—CYP3A4—renal system—prostate cancer	0.000317	0.0137	CbGeAlD
Terbinafine—CYP2D6—renal system—prostate cancer	0.000312	0.0135	CbGeAlD
Terbinafine—CYP19A1—lymph node—prostate cancer	0.000306	0.0132	CbGeAlD
Terbinafine—CYP2C8—testis—prostate cancer	0.000303	0.0131	CbGeAlD
Terbinafine—PTGS1—testis—prostate cancer	0.000245	0.0106	CbGeAlD
Terbinafine—CYP2D6—testis—prostate cancer	0.000202	0.00872	CbGeAlD
Terbinafine—PTGS1—lymph node—prostate cancer	0.000178	0.00769	CbGeAlD
Terbinafine—Propranolol—CYP3A5—prostate cancer	0.00015	0.279	CrCbGaD
Terbinafine—Propranolol—ADRB2—prostate cancer	0.000119	0.221	CrCbGaD
Terbinafine—Propranolol—CYP2C19—prostate cancer	0.000102	0.19	CrCbGaD
Terbinafine—Propranolol—CYP1A1—prostate cancer	0.000102	0.189	CrCbGaD
Terbinafine—Propranolol—CYP3A4—prostate cancer	6.51e-05	0.121	CrCbGaD
Terbinafine—Upper respiratory tract infection—Doxorubicin—prostate cancer	4.89e-05	0.000375	CcSEcCtD
Terbinafine—Arthralgia—Capecitabine—prostate cancer	4.84e-05	0.000371	CcSEcCtD
Terbinafine—Chest pain—Capecitabine—prostate cancer	4.84e-05	0.000371	CcSEcCtD
Terbinafine—Myalgia—Capecitabine—prostate cancer	4.84e-05	0.000371	CcSEcCtD
Terbinafine—Confusional state—Docetaxel—prostate cancer	4.84e-05	0.000371	CcSEcCtD
Terbinafine—Anxiety—Capecitabine—prostate cancer	4.83e-05	0.00037	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	4.81e-05	0.000369	CcSEcCtD
Terbinafine—Photosensitivity reaction—Doxorubicin—prostate cancer	4.8e-05	0.000368	CcSEcCtD
Terbinafine—Hepatobiliary disease—Epirubicin—prostate cancer	4.8e-05	0.000368	CcSEcCtD
Terbinafine—Anaphylactic shock—Docetaxel—prostate cancer	4.8e-05	0.000368	CcSEcCtD
Terbinafine—Discomfort—Capecitabine—prostate cancer	4.79e-05	0.000367	CcSEcCtD
Terbinafine—Vision blurred—Prednisone—prostate cancer	4.78e-05	0.000366	CcSEcCtD
Terbinafine—Infection—Docetaxel—prostate cancer	4.76e-05	0.000365	CcSEcCtD
Terbinafine—Weight decreased—Doxorubicin—prostate cancer	4.76e-05	0.000365	CcSEcCtD
Terbinafine—Feeling abnormal—Etoposide—prostate cancer	4.76e-05	0.000365	CcSEcCtD
Terbinafine—Diarrhoea—Mitoxantrone—prostate cancer	4.75e-05	0.000364	CcSEcCtD
Terbinafine—Dry mouth—Capecitabine—prostate cancer	4.74e-05	0.000363	CcSEcCtD
Terbinafine—Vomiting—Estradiol—prostate cancer	4.73e-05	0.000363	CcSEcCtD
Terbinafine—Agranulocytosis—Epirubicin—prostate cancer	4.73e-05	0.000363	CcSEcCtD
Terbinafine—Gastrointestinal pain—Etoposide—prostate cancer	4.72e-05	0.000362	CcSEcCtD
Terbinafine—Nervous system disorder—Docetaxel—prostate cancer	4.7e-05	0.000361	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisone—prostate cancer	4.7e-05	0.000361	CcSEcCtD
Terbinafine—Thrombocytopenia—Docetaxel—prostate cancer	4.7e-05	0.00036	CcSEcCtD
Terbinafine—Rash—Estradiol—prostate cancer	4.69e-05	0.00036	CcSEcCtD
Terbinafine—Infestation—Doxorubicin—prostate cancer	4.69e-05	0.00036	CcSEcCtD
Terbinafine—Infestation NOS—Doxorubicin—prostate cancer	4.69e-05	0.00036	CcSEcCtD
Terbinafine—Dermatitis—Estradiol—prostate cancer	4.69e-05	0.00036	CcSEcCtD
Terbinafine—Anaemia—Prednisone—prostate cancer	4.68e-05	0.000359	CcSEcCtD
Terbinafine—Confusional state—Capecitabine—prostate cancer	4.68e-05	0.000359	CcSEcCtD
Terbinafine—Headache—Estradiol—prostate cancer	4.66e-05	0.000358	CcSEcCtD
Terbinafine—Skin disorder—Docetaxel—prostate cancer	4.66e-05	0.000357	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	4.65e-05	0.000357	CcSEcCtD
Terbinafine—Angioedema—Prednisone—prostate cancer	4.63e-05	0.000355	CcSEcCtD
Terbinafine—Infection—Capecitabine—prostate cancer	4.61e-05	0.000354	CcSEcCtD
Terbinafine—Urticaria—Etoposide—prostate cancer	4.58e-05	0.000352	CcSEcCtD
Terbinafine—Jaundice—Doxorubicin—prostate cancer	4.57e-05	0.000351	CcSEcCtD
Terbinafine—Anorexia—Docetaxel—prostate cancer	4.57e-05	0.000351	CcSEcCtD
Terbinafine—Malaise—Prednisone—prostate cancer	4.57e-05	0.00035	CcSEcCtD
Terbinafine—Abdominal pain—Etoposide—prostate cancer	4.56e-05	0.00035	CcSEcCtD
Terbinafine—Body temperature increased—Etoposide—prostate cancer	4.56e-05	0.00035	CcSEcCtD
Terbinafine—Nervous system disorder—Capecitabine—prostate cancer	4.55e-05	0.000349	CcSEcCtD
Terbinafine—Vertigo—Prednisone—prostate cancer	4.55e-05	0.000349	CcSEcCtD
Terbinafine—Hepatitis—Epirubicin—prostate cancer	4.55e-05	0.000349	CcSEcCtD
Terbinafine—Thrombocytopenia—Capecitabine—prostate cancer	4.55e-05	0.000349	CcSEcCtD
Terbinafine—Hypoaesthesia—Epirubicin—prostate cancer	4.53e-05	0.000347	CcSEcCtD
Terbinafine—Skin disorder—Capecitabine—prostate cancer	4.51e-05	0.000346	CcSEcCtD
Terbinafine—Connective tissue disorder—Epirubicin—prostate cancer	4.47e-05	0.000343	CcSEcCtD
Terbinafine—Hepatobiliary disease—Doxorubicin—prostate cancer	4.44e-05	0.00034	CcSEcCtD
Terbinafine—Anorexia—Capecitabine—prostate cancer	4.43e-05	0.000339	CcSEcCtD
Terbinafine—Nausea—Estradiol—prostate cancer	4.42e-05	0.000339	CcSEcCtD
Terbinafine—Vomiting—Mitoxantrone—prostate cancer	4.41e-05	0.000338	CcSEcCtD
Terbinafine—Visual impairment—Epirubicin—prostate cancer	4.39e-05	0.000336	CcSEcCtD
Terbinafine—Agranulocytosis—Doxorubicin—prostate cancer	4.38e-05	0.000336	CcSEcCtD
Terbinafine—Rash—Mitoxantrone—prostate cancer	4.37e-05	0.000335	CcSEcCtD
Terbinafine—Dermatitis—Mitoxantrone—prostate cancer	4.37e-05	0.000335	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.37e-05	0.000335	CcSEcCtD
Terbinafine—Headache—Mitoxantrone—prostate cancer	4.35e-05	0.000333	CcSEcCtD
Terbinafine—Myalgia—Prednisone—prostate cancer	4.31e-05	0.000331	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—prostate cancer	4.31e-05	0.000331	CcSEcCtD
Terbinafine—Paraesthesia—Docetaxel—prostate cancer	4.31e-05	0.00033	CcSEcCtD
Terbinafine—Erythema multiforme—Epirubicin—prostate cancer	4.31e-05	0.00033	CcSEcCtD
Terbinafine—Anxiety—Prednisone—prostate cancer	4.3e-05	0.00033	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.28e-05	0.000329	CcSEcCtD
Terbinafine—Discomfort—Prednisone—prostate cancer	4.26e-05	0.000327	CcSEcCtD
Terbinafine—Eye disorder—Epirubicin—prostate cancer	4.26e-05	0.000326	CcSEcCtD
Terbinafine—Hypersensitivity—Etoposide—prostate cancer	4.25e-05	0.000326	CcSEcCtD
Terbinafine—Tinnitus—Epirubicin—prostate cancer	4.25e-05	0.000326	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.23e-05	0.000324	CcSEcCtD
Terbinafine—Dyspepsia—Docetaxel—prostate cancer	4.22e-05	0.000324	CcSEcCtD
Terbinafine—Hepatitis—Doxorubicin—prostate cancer	4.21e-05	0.000323	CcSEcCtD
Terbinafine—Hypoaesthesia—Doxorubicin—prostate cancer	4.19e-05	0.000321	CcSEcCtD
Terbinafine—Paraesthesia—Capecitabine—prostate cancer	4.17e-05	0.00032	CcSEcCtD
Terbinafine—Decreased appetite—Docetaxel—prostate cancer	4.17e-05	0.00032	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Docetaxel—prostate cancer	4.14e-05	0.000317	CcSEcCtD
Terbinafine—Asthenia—Etoposide—prostate cancer	4.14e-05	0.000317	CcSEcCtD
Terbinafine—Connective tissue disorder—Doxorubicin—prostate cancer	4.14e-05	0.000317	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—prostate cancer	4.14e-05	0.000317	CcSEcCtD
Terbinafine—Fatigue—Docetaxel—prostate cancer	4.13e-05	0.000317	CcSEcCtD
Terbinafine—Angiopathy—Epirubicin—prostate cancer	4.13e-05	0.000317	CcSEcCtD
Terbinafine—Nausea—Mitoxantrone—prostate cancer	4.12e-05	0.000316	CcSEcCtD
Terbinafine—Immune system disorder—Epirubicin—prostate cancer	4.11e-05	0.000315	CcSEcCtD
Terbinafine—Infection—Prednisone—prostate cancer	4.11e-05	0.000315	CcSEcCtD
Terbinafine—Pain—Docetaxel—prostate cancer	4.1e-05	0.000314	CcSEcCtD
Terbinafine—Dyspepsia—Capecitabine—prostate cancer	4.09e-05	0.000313	CcSEcCtD
Terbinafine—Pruritus—Etoposide—prostate cancer	4.08e-05	0.000313	CcSEcCtD
Terbinafine—Visual impairment—Doxorubicin—prostate cancer	4.06e-05	0.000311	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—prostate cancer	4.06e-05	0.000311	CcSEcCtD
Terbinafine—Decreased appetite—Capecitabine—prostate cancer	4.04e-05	0.000309	CcSEcCtD
Terbinafine—Alopecia—Epirubicin—prostate cancer	4.02e-05	0.000309	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—prostate cancer	4.02e-05	0.000308	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Capecitabine—prostate cancer	4.01e-05	0.000307	CcSEcCtD
Terbinafine—Fatigue—Capecitabine—prostate cancer	4e-05	0.000307	CcSEcCtD
Terbinafine—Mental disorder—Epirubicin—prostate cancer	3.99e-05	0.000306	CcSEcCtD
Terbinafine—Erythema multiforme—Doxorubicin—prostate cancer	3.98e-05	0.000305	CcSEcCtD
Terbinafine—Pain—Capecitabine—prostate cancer	3.97e-05	0.000304	CcSEcCtD
Terbinafine—Erythema—Epirubicin—prostate cancer	3.96e-05	0.000304	CcSEcCtD
Terbinafine—Feeling abnormal—Docetaxel—prostate cancer	3.95e-05	0.000303	CcSEcCtD
Terbinafine—Diarrhoea—Etoposide—prostate cancer	3.95e-05	0.000303	CcSEcCtD
Terbinafine—Anorexia—Prednisone—prostate cancer	3.94e-05	0.000302	CcSEcCtD
Terbinafine—Eye disorder—Doxorubicin—prostate cancer	3.94e-05	0.000302	CcSEcCtD
Terbinafine—Tinnitus—Doxorubicin—prostate cancer	3.93e-05	0.000301	CcSEcCtD
Terbinafine—Gastrointestinal pain—Docetaxel—prostate cancer	3.92e-05	0.000301	CcSEcCtD
Terbinafine—Flatulence—Epirubicin—prostate cancer	3.91e-05	0.000299	CcSEcCtD
Terbinafine—Dysgeusia—Epirubicin—prostate cancer	3.88e-05	0.000298	CcSEcCtD
Terbinafine—Feeling abnormal—Capecitabine—prostate cancer	3.83e-05	0.000293	CcSEcCtD
Terbinafine—Angiopathy—Doxorubicin—prostate cancer	3.82e-05	0.000293	CcSEcCtD
Terbinafine—Dizziness—Etoposide—prostate cancer	3.82e-05	0.000293	CcSEcCtD
Terbinafine—Muscle spasms—Epirubicin—prostate cancer	3.81e-05	0.000292	CcSEcCtD
Terbinafine—Immune system disorder—Doxorubicin—prostate cancer	3.81e-05	0.000292	CcSEcCtD
Terbinafine—Gastrointestinal pain—Capecitabine—prostate cancer	3.8e-05	0.000291	CcSEcCtD
Terbinafine—Abdominal pain—Docetaxel—prostate cancer	3.79e-05	0.000291	CcSEcCtD
Terbinafine—Body temperature increased—Docetaxel—prostate cancer	3.79e-05	0.000291	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—prostate cancer	3.77e-05	0.000289	CcSEcCtD
Terbinafine—Vision blurred—Epirubicin—prostate cancer	3.74e-05	0.000286	CcSEcCtD
Terbinafine—Alopecia—Doxorubicin—prostate cancer	3.72e-05	0.000285	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—prostate cancer	3.71e-05	0.000285	CcSEcCtD
Terbinafine—Mental disorder—Doxorubicin—prostate cancer	3.69e-05	0.000283	CcSEcCtD
Terbinafine—Urticaria—Capecitabine—prostate cancer	3.69e-05	0.000283	CcSEcCtD
Terbinafine—Ill-defined disorder—Epirubicin—prostate cancer	3.68e-05	0.000282	CcSEcCtD
Terbinafine—Abdominal pain—Capecitabine—prostate cancer	3.67e-05	0.000281	CcSEcCtD
Terbinafine—Body temperature increased—Capecitabine—prostate cancer	3.67e-05	0.000281	CcSEcCtD
Terbinafine—Vomiting—Etoposide—prostate cancer	3.67e-05	0.000281	CcSEcCtD
Terbinafine—Erythema—Doxorubicin—prostate cancer	3.67e-05	0.000281	CcSEcCtD
Terbinafine—Anaemia—Epirubicin—prostate cancer	3.66e-05	0.000281	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—prostate cancer	3.64e-05	0.000279	CcSEcCtD
Terbinafine—Rash—Etoposide—prostate cancer	3.64e-05	0.000279	CcSEcCtD
Terbinafine—Dermatitis—Etoposide—prostate cancer	3.64e-05	0.000279	CcSEcCtD
Terbinafine—Headache—Etoposide—prostate cancer	3.62e-05	0.000277	CcSEcCtD
Terbinafine—Flatulence—Doxorubicin—prostate cancer	3.61e-05	0.000277	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—prostate cancer	3.6e-05	0.000276	CcSEcCtD
Terbinafine—Dysgeusia—Doxorubicin—prostate cancer	3.59e-05	0.000275	CcSEcCtD
Terbinafine—Malaise—Epirubicin—prostate cancer	3.57e-05	0.000274	CcSEcCtD
Terbinafine—Fatigue—Prednisone—prostate cancer	3.57e-05	0.000273	CcSEcCtD
Terbinafine—Vertigo—Epirubicin—prostate cancer	3.56e-05	0.000273	CcSEcCtD
Terbinafine—Hypersensitivity—Docetaxel—prostate cancer	3.53e-05	0.000271	CcSEcCtD
Terbinafine—Muscle spasms—Doxorubicin—prostate cancer	3.53e-05	0.00027	CcSEcCtD
Terbinafine—Cough—Epirubicin—prostate cancer	3.46e-05	0.000265	CcSEcCtD
Terbinafine—Vision blurred—Doxorubicin—prostate cancer	3.46e-05	0.000265	CcSEcCtD
Terbinafine—Asthenia—Docetaxel—prostate cancer	3.44e-05	0.000264	CcSEcCtD
Terbinafine—Nausea—Etoposide—prostate cancer	3.43e-05	0.000263	CcSEcCtD
Terbinafine—Hypersensitivity—Capecitabine—prostate cancer	3.42e-05	0.000262	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisone—prostate cancer	3.41e-05	0.000261	CcSEcCtD
Terbinafine—Ill-defined disorder—Doxorubicin—prostate cancer	3.4e-05	0.000261	CcSEcCtD
Terbinafine—Pruritus—Docetaxel—prostate cancer	3.39e-05	0.00026	CcSEcCtD
Terbinafine—Anaemia—Doxorubicin—prostate cancer	3.39e-05	0.00026	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—prostate cancer	3.38e-05	0.000259	CcSEcCtD
Terbinafine—Arthralgia—Epirubicin—prostate cancer	3.37e-05	0.000259	CcSEcCtD
Terbinafine—Myalgia—Epirubicin—prostate cancer	3.37e-05	0.000259	CcSEcCtD
Terbinafine—Chest pain—Epirubicin—prostate cancer	3.37e-05	0.000259	CcSEcCtD
Terbinafine—Anxiety—Epirubicin—prostate cancer	3.36e-05	0.000258	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.35e-05	0.000257	CcSEcCtD
Terbinafine—Discomfort—Epirubicin—prostate cancer	3.33e-05	0.000256	CcSEcCtD
Terbinafine—Asthenia—Capecitabine—prostate cancer	3.33e-05	0.000255	CcSEcCtD
Terbinafine—Malaise—Doxorubicin—prostate cancer	3.31e-05	0.000254	CcSEcCtD
Terbinafine—Dry mouth—Epirubicin—prostate cancer	3.3e-05	0.000253	CcSEcCtD
Terbinafine—Vertigo—Doxorubicin—prostate cancer	3.3e-05	0.000253	CcSEcCtD
Terbinafine—Urticaria—Prednisone—prostate cancer	3.29e-05	0.000252	CcSEcCtD
Terbinafine—Pruritus—Capecitabine—prostate cancer	3.29e-05	0.000252	CcSEcCtD
Terbinafine—Diarrhoea—Docetaxel—prostate cancer	3.28e-05	0.000252	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—prostate cancer	3.27e-05	0.000251	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—prostate cancer	3.27e-05	0.000251	CcSEcCtD
Terbinafine—Confusional state—Epirubicin—prostate cancer	3.26e-05	0.00025	CcSEcCtD
Terbinafine—Anaphylactic shock—Epirubicin—prostate cancer	3.23e-05	0.000248	CcSEcCtD
Terbinafine—Infection—Epirubicin—prostate cancer	3.21e-05	0.000246	CcSEcCtD
Terbinafine—Cough—Doxorubicin—prostate cancer	3.2e-05	0.000245	CcSEcCtD
Terbinafine—Diarrhoea—Capecitabine—prostate cancer	3.18e-05	0.000244	CcSEcCtD
Terbinafine—Nervous system disorder—Epirubicin—prostate cancer	3.17e-05	0.000243	CcSEcCtD
Terbinafine—Dizziness—Docetaxel—prostate cancer	3.17e-05	0.000243	CcSEcCtD
Terbinafine—Thrombocytopenia—Epirubicin—prostate cancer	3.17e-05	0.000243	CcSEcCtD
Terbinafine—Skin disorder—Epirubicin—prostate cancer	3.14e-05	0.000241	CcSEcCtD
Terbinafine—Myalgia—Doxorubicin—prostate cancer	3.12e-05	0.000239	CcSEcCtD
Terbinafine—Chest pain—Doxorubicin—prostate cancer	3.12e-05	0.000239	CcSEcCtD
Terbinafine—Arthralgia—Doxorubicin—prostate cancer	3.12e-05	0.000239	CcSEcCtD
Terbinafine—Anxiety—Doxorubicin—prostate cancer	3.11e-05	0.000239	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.1e-05	0.000238	CcSEcCtD
Terbinafine—Discomfort—Doxorubicin—prostate cancer	3.08e-05	0.000237	CcSEcCtD
Terbinafine—Anorexia—Epirubicin—prostate cancer	3.08e-05	0.000236	CcSEcCtD
Terbinafine—Dizziness—Capecitabine—prostate cancer	3.07e-05	0.000235	CcSEcCtD
Terbinafine—Dry mouth—Doxorubicin—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Terbinafine—Vomiting—Docetaxel—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisone—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Terbinafine—Rash—Docetaxel—prostate cancer	3.02e-05	0.000232	CcSEcCtD
Terbinafine—Dermatitis—Docetaxel—prostate cancer	3.02e-05	0.000232	CcSEcCtD
Terbinafine—Confusional state—Doxorubicin—prostate cancer	3.02e-05	0.000231	CcSEcCtD
Terbinafine—Headache—Docetaxel—prostate cancer	3e-05	0.00023	CcSEcCtD
Terbinafine—Anaphylactic shock—Doxorubicin—prostate cancer	2.99e-05	0.000229	CcSEcCtD
Terbinafine—Infection—Doxorubicin—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Terbinafine—Asthenia—Prednisone—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Terbinafine—Vomiting—Capecitabine—prostate cancer	2.95e-05	0.000226	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.95e-05	0.000226	CcSEcCtD
Terbinafine—Nervous system disorder—Doxorubicin—prostate cancer	2.94e-05	0.000225	CcSEcCtD
Terbinafine—Thrombocytopenia—Doxorubicin—prostate cancer	2.93e-05	0.000225	CcSEcCtD
Terbinafine—Rash—Capecitabine—prostate cancer	2.93e-05	0.000224	CcSEcCtD
Terbinafine—Pruritus—Prednisone—prostate cancer	2.93e-05	0.000224	CcSEcCtD
Terbinafine—Dermatitis—Capecitabine—prostate cancer	2.93e-05	0.000224	CcSEcCtD
Terbinafine—Headache—Capecitabine—prostate cancer	2.91e-05	0.000223	CcSEcCtD
Terbinafine—Skin disorder—Doxorubicin—prostate cancer	2.91e-05	0.000223	CcSEcCtD
Terbinafine—Paraesthesia—Epirubicin—prostate cancer	2.9e-05	0.000223	CcSEcCtD
Terbinafine—Anorexia—Doxorubicin—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Terbinafine—Nausea—Docetaxel—prostate cancer	2.85e-05	0.000218	CcSEcCtD
Terbinafine—Dyspepsia—Epirubicin—prostate cancer	2.85e-05	0.000218	CcSEcCtD
Terbinafine—Diarrhoea—Prednisone—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Terbinafine—Decreased appetite—Epirubicin—prostate cancer	2.81e-05	0.000216	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.79e-05	0.000214	CcSEcCtD
Terbinafine—Fatigue—Epirubicin—prostate cancer	2.79e-05	0.000214	CcSEcCtD
Terbinafine—Pain—Epirubicin—prostate cancer	2.77e-05	0.000212	CcSEcCtD
Terbinafine—Nausea—Capecitabine—prostate cancer	2.76e-05	0.000211	CcSEcCtD
Terbinafine—Dizziness—Prednisone—prostate cancer	2.74e-05	0.00021	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.73e-05	0.000209	CcSEcCtD
Terbinafine—Paraesthesia—Doxorubicin—prostate cancer	2.69e-05	0.000206	CcSEcCtD
Terbinafine—Feeling abnormal—Epirubicin—prostate cancer	2.67e-05	0.000204	CcSEcCtD
Terbinafine—Gastrointestinal pain—Epirubicin—prostate cancer	2.65e-05	0.000203	CcSEcCtD
Terbinafine—Dyspepsia—Doxorubicin—prostate cancer	2.63e-05	0.000202	CcSEcCtD
Terbinafine—Vomiting—Prednisone—prostate cancer	2.63e-05	0.000202	CcSEcCtD
Terbinafine—Rash—Prednisone—prostate cancer	2.61e-05	0.0002	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—prostate cancer	2.61e-05	0.0002	CcSEcCtD
Terbinafine—Decreased appetite—Doxorubicin—prostate cancer	2.6e-05	0.0002	CcSEcCtD
Terbinafine—Headache—Prednisone—prostate cancer	2.59e-05	0.000199	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.58e-05	0.000198	CcSEcCtD
Terbinafine—Fatigue—Doxorubicin—prostate cancer	2.58e-05	0.000198	CcSEcCtD
Terbinafine—Urticaria—Epirubicin—prostate cancer	2.57e-05	0.000197	CcSEcCtD
Terbinafine—Pain—Doxorubicin—prostate cancer	2.56e-05	0.000196	CcSEcCtD
Terbinafine—Abdominal pain—Epirubicin—prostate cancer	2.56e-05	0.000196	CcSEcCtD
Terbinafine—Body temperature increased—Epirubicin—prostate cancer	2.56e-05	0.000196	CcSEcCtD
Terbinafine—Feeling abnormal—Doxorubicin—prostate cancer	2.47e-05	0.000189	CcSEcCtD
Terbinafine—Nausea—Prednisone—prostate cancer	2.46e-05	0.000188	CcSEcCtD
Terbinafine—Gastrointestinal pain—Doxorubicin—prostate cancer	2.45e-05	0.000188	CcSEcCtD
Terbinafine—Hypersensitivity—Epirubicin—prostate cancer	2.38e-05	0.000183	CcSEcCtD
Terbinafine—Urticaria—Doxorubicin—prostate cancer	2.38e-05	0.000182	CcSEcCtD
Terbinafine—Body temperature increased—Doxorubicin—prostate cancer	2.37e-05	0.000181	CcSEcCtD
Terbinafine—Abdominal pain—Doxorubicin—prostate cancer	2.37e-05	0.000181	CcSEcCtD
Terbinafine—Asthenia—Epirubicin—prostate cancer	2.32e-05	0.000178	CcSEcCtD
Terbinafine—Pruritus—Epirubicin—prostate cancer	2.29e-05	0.000175	CcSEcCtD
Terbinafine—Diarrhoea—Epirubicin—prostate cancer	2.21e-05	0.00017	CcSEcCtD
Terbinafine—Hypersensitivity—Doxorubicin—prostate cancer	2.21e-05	0.000169	CcSEcCtD
Terbinafine—Asthenia—Doxorubicin—prostate cancer	2.15e-05	0.000165	CcSEcCtD
Terbinafine—Dizziness—Epirubicin—prostate cancer	2.14e-05	0.000164	CcSEcCtD
Terbinafine—Pruritus—Doxorubicin—prostate cancer	2.12e-05	0.000162	CcSEcCtD
Terbinafine—Vomiting—Epirubicin—prostate cancer	2.06e-05	0.000158	CcSEcCtD
Terbinafine—Diarrhoea—Doxorubicin—prostate cancer	2.05e-05	0.000157	CcSEcCtD
Terbinafine—Rash—Epirubicin—prostate cancer	2.04e-05	0.000156	CcSEcCtD
Terbinafine—Dermatitis—Epirubicin—prostate cancer	2.04e-05	0.000156	CcSEcCtD
Terbinafine—Headache—Epirubicin—prostate cancer	2.03e-05	0.000155	CcSEcCtD
Terbinafine—Dizziness—Doxorubicin—prostate cancer	1.98e-05	0.000152	CcSEcCtD
Terbinafine—Nausea—Epirubicin—prostate cancer	1.92e-05	0.000147	CcSEcCtD
Terbinafine—Vomiting—Doxorubicin—prostate cancer	1.9e-05	0.000146	CcSEcCtD
Terbinafine—Rash—Doxorubicin—prostate cancer	1.89e-05	0.000145	CcSEcCtD
Terbinafine—Dermatitis—Doxorubicin—prostate cancer	1.89e-05	0.000145	CcSEcCtD
Terbinafine—Headache—Doxorubicin—prostate cancer	1.88e-05	0.000144	CcSEcCtD
Terbinafine—Nausea—Doxorubicin—prostate cancer	1.78e-05	0.000136	CcSEcCtD
Terbinafine—CYP3A4—Metabolism—GSTA2—prostate cancer	2.35e-06	2.08e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP3A4—prostate cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—RXRA—prostate cancer	2.34e-06	2.07e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NOS3—prostate cancer	2.34e-06	2.07e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.33e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HPGDS—prostate cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ABCG5—prostate cancer	2.32e-06	2.06e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.31e-06	2.04e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.31e-06	2.04e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.29e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.28e-06	2.02e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.27e-06	2.01e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.27e-06	2.01e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—COMT—prostate cancer	2.26e-06	2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ACHE—prostate cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTP1—prostate cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—INS—prostate cancer	2.25e-06	1.99e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAT2—prostate cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GGT1—prostate cancer	2.23e-06	1.97e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.23e-06	1.97e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.22e-06	1.96e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.22e-06	1.96e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NQO1—prostate cancer	2.21e-06	1.96e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ITPR1—prostate cancer	2.21e-06	1.96e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CREBBP—prostate cancer	2.2e-06	1.95e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.2e-06	1.95e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NQO1—prostate cancer	2.19e-06	1.94e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TH—prostate cancer	2.18e-06	1.93e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.17e-06	1.92e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.17e-06	1.92e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.17e-06	1.92e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TH—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CB—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.16e-06	1.91e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LRP2—prostate cancer	2.15e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.15e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.15e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.15e-06	1.9e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—prostate cancer	2.14e-06	1.89e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.14e-06	1.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.13e-06	1.89e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.13e-06	1.88e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.12e-06	1.88e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—P4HB—prostate cancer	2.11e-06	1.87e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.11e-06	1.86e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.1e-06	1.86e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—RXRA—prostate cancer	2.09e-06	1.85e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—TYMS—prostate cancer	2.09e-06	1.85e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CD—prostate cancer	2.09e-06	1.85e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—prostate cancer	2.07e-06	1.83e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GGT1—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GGT1—prostate cancer	2.04e-06	1.8e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.03e-06	1.8e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.03e-06	1.8e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—LPL—prostate cancer	2.03e-06	1.79e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.02e-06	1.79e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—COMT—prostate cancer	2.02e-06	1.78e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NCOA1—prostate cancer	2.01e-06	1.77e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.99e-06	1.76e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PIK3CA—prostate cancer	1.99e-06	1.76e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.98e-06	1.75e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ITPR1—prostate cancer	1.97e-06	1.75e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NOS3—prostate cancer	1.97e-06	1.74e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MED12—prostate cancer	1.97e-06	1.74e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.96e-06	1.73e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GNG5—prostate cancer	1.95e-06	1.73e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ERCC2—prostate cancer	1.94e-06	1.72e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.94e-06	1.72e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.94e-06	1.72e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—RXRA—prostate cancer	1.92e-06	1.7e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—RXRA—prostate cancer	1.91e-06	1.69e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.9e-06	1.68e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA3—prostate cancer	1.88e-06	1.66e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NQO1—prostate cancer	1.87e-06	1.66e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTEN—prostate cancer	1.87e-06	1.65e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—TYMS—prostate cancer	1.86e-06	1.65e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.86e-06	1.64e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—COMT—prostate cancer	1.85e-06	1.64e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TH—prostate cancer	1.85e-06	1.63e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTP1—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—COMT—prostate cancer	1.84e-06	1.63e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTP1—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.83e-06	1.62e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—prostate cancer	1.83e-06	1.61e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CB—prostate cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ITPR1—prostate cancer	1.82e-06	1.61e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—LPL—prostate cancer	1.81e-06	1.6e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ITPR1—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HPGDS—prostate cancer	1.79e-06	1.59e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARA—prostate cancer	1.79e-06	1.58e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.78e-06	1.58e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—EP300—prostate cancer	1.78e-06	1.57e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.77e-06	1.56e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.75e-06	1.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTT1—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ACHE—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GGT1—prostate cancer	1.74e-06	1.54e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ERCC2—prostate cancer	1.73e-06	1.53e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.72e-06	1.52e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—TYMS—prostate cancer	1.72e-06	1.52e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NCOA1—prostate cancer	1.71e-06	1.52e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—TYMS—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—prostate cancer	1.7e-06	1.5e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.69e-06	1.49e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAV1—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—prostate cancer	1.68e-06	1.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.67e-06	1.48e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PRKACB—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—LPL—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—LPL—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.65e-06	1.46e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—RXRA—prostate cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—prostate cancer	1.63e-06	1.44e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—prostate cancer	1.62e-06	1.44e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.61e-06	1.42e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.61e-06	1.42e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARA—prostate cancer	1.6e-06	1.41e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ERCC2—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.59e-06	1.41e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.59e-06	1.4e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ERCC2—prostate cancer	1.58e-06	1.4e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTEN—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—COMT—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA2—prostate cancer	1.57e-06	1.39e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTP1—prostate cancer	1.56e-06	1.38e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.54e-06	1.36e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.53e-06	1.36e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.51e-06	1.34e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAV1—prostate cancer	1.5e-06	1.33e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—EP300—prostate cancer	1.5e-06	1.33e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.5e-06	1.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.5e-06	1.32e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—prostate cancer	1.49e-06	1.31e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARA—prostate cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.46e-06	1.29e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARA—prostate cancer	1.46e-06	1.29e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—TYMS—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—INS—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NQO1—prostate cancer	1.45e-06	1.28e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.44e-06	1.27e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.44e-06	1.27e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TH—prostate cancer	1.43e-06	1.26e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CREBBP—prostate cancer	1.42e-06	1.26e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LPL—prostate cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.39e-06	1.23e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAV1—prostate cancer	1.38e-06	1.22e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAV1—prostate cancer	1.37e-06	1.21e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.37e-06	1.21e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.36e-06	1.2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.35e-06	1.19e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.35e-06	1.19e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GGT1—prostate cancer	1.34e-06	1.19e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3CA—prostate cancer	1.32e-06	1.17e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.31e-06	1.16e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—INS—prostate cancer	1.3e-06	1.15e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NOS3—prostate cancer	1.27e-06	1.13e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—RXRA—prostate cancer	1.26e-06	1.11e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.25e-06	1.1e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARA—prostate cancer	1.25e-06	1.1e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—COMT—prostate cancer	1.21e-06	1.07e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.21e-06	1.07e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.2e-06	1.06e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—INS—prostate cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.19e-06	1.05e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—INS—prostate cancer	1.18e-06	1.04e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAV1—prostate cancer	1.17e-06	1.04e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.17e-06	1.03e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—prostate cancer	1.16e-06	1.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CREBBP—prostate cancer	1.16e-06	1.02e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NOS3—prostate cancer	1.14e-06	1e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—TYMS—prostate cancer	1.12e-06	9.92e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.12e-06	9.89e-06	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3CA—prostate cancer	1.11e-06	9.81e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.11e-06	9.8e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.11e-06	9.79e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.1e-06	9.7e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LPL—prostate cancer	1.09e-06	9.62e-06	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—prostate cancer	1.08e-06	9.52e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.07e-06	9.43e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.05e-06	9.29e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.05e-06	9.27e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NOS3—prostate cancer	1.05e-06	9.24e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.04e-06	9.22e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.04e-06	9.19e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NOS3—prostate cancer	1.04e-06	9.16e-06	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTEN—prostate cancer	1.02e-06	8.98e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—INS—prostate cancer	1.01e-06	8.93e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CREBBP—prostate cancer	9.89e-07	8.74e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—prostate cancer	9.8e-07	8.66e-06	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—EP300—prostate cancer	9.68e-07	8.56e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.65e-07	8.53e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARA—prostate cancer	9.61e-07	8.5e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CB—prostate cancer	9.56e-07	8.46e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—prostate cancer	9.56e-07	8.45e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—prostate cancer	9.48e-07	8.38e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CD—prostate cancer	9.38e-07	8.29e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTEN—prostate cancer	9.06e-07	8.01e-06	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—prostate cancer	9.06e-07	8.01e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAV1—prostate cancer	9.04e-07	7.99e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NOS3—prostate cancer	8.85e-07	7.83e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—EP300—prostate cancer	8.64e-07	7.64e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTEN—prostate cancer	8.34e-07	7.37e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTEN—prostate cancer	8.26e-07	7.31e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.23e-07	7.28e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CB—prostate cancer	8.17e-07	7.23e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—prostate cancer	8.1e-07	7.16e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—EP300—prostate cancer	7.95e-07	7.03e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—EP300—prostate cancer	7.88e-07	6.97e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—INS—prostate cancer	7.79e-07	6.89e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CREBBP—prostate cancer	7.63e-07	6.75e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.24e-07	6.4e-06	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3CA—prostate cancer	7.16e-07	6.33e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTEN—prostate cancer	7.06e-07	6.24e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NOS3—prostate cancer	6.83e-07	6.04e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—EP300—prostate cancer	6.73e-07	5.96e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3CA—prostate cancer	6.39e-07	5.65e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.31e-07	5.58e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—prostate cancer	6.25e-07	5.53e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.88e-07	5.2e-06	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—prostate cancer	5.85e-07	5.17e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.83e-07	5.16e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTEN—prostate cancer	5.45e-07	4.82e-06	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—prostate cancer	5.22e-07	4.62e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—EP300—prostate cancer	5.2e-07	4.6e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.98e-07	4.41e-06	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—prostate cancer	4.8e-07	4.25e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—prostate cancer	4.76e-07	4.21e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—prostate cancer	4.07e-07	3.6e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.84e-07	3.4e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—prostate cancer	3.14e-07	2.78e-06	CbGpPWpGaD
